Grow Your Practice with AdaptDx Pro
There’s only one test that can measure dark adaptation speed quickly and effectively in a clinical setting. See how the AdaptDx Pro® can enhance your diagnostic ability, promote objective disease monitoring, and help you grow your business.
Earlier Diagnosis and More Effective Monitoring
By testing your patients with AdaptDx Pro, you may uncover new cases of subclinical and early AMD. In fact, when administering the AdaptDx Pro Rapid Test on all patients 50 years and older, current users are uncovering a significant number of patients with impaired dark adaptation speed. When a patient’s Rod Intercept® (RI®) is 6.5 or higher, it alerts the eye care professional to further examine the patient for signs of retinal disfunction, including AMD.
Once AMD is detected, dark adaptation testing allows you to monitor disease progression at regular intervals and identify fast progressors. In turn, more frequent visits and proactive treatment often results in improved outcomes and patient compliance—and has the potential for boosting practice revenue.
Identifying AMD patients as well as patients at risk of AMD may also lead to additional revenue from sales of nutraceuticals, blue light blocking lenses and protective sunglasses. Each AdaptDx Pro purchase is supported by our AMD Excellence Program® – a core component of every device subscription.
Empowering Eye Care Technicians as AMD Champions
Dark Adaptation Testing is Reimbursable
- CPT Code 92284 for dark adaptation
- $58.83 average national reimbursement
- Co-billable with OCT, fundus imaging, visual field, and/or office visits
- Multiple ICD-10 codes based on medical necessity
Thanks to the comprehensive AMD Excellence training program from MacuLogix, each staff member - from the front desk and optical, to technicians and billing - understands the important role they play in AMD care.